LINCOLN PHARMACEUTICALS LTD. - 531633 - Board Meeting Outcome for Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2023
Financial Results (standalone and consolidated) for the Quarter and Year Ended March 31, 202325-05-2023